Subsequently, we performed a co‐IP assay to analyze the endogenous MCT1 methylation in CRC cells, and the results showed that downregulating SETDB1 or treatment with Mithramycin A led to a significant decrease in MCT1 tri‐methylation (Figure 3a and Figure S3b, Supporting Information). This evidence concerns the gene SETDB1 and colorectal carcinoma.